Merck to buy immunotherapy developer Immune Design for $300 million

Merck to buy immunotherapy developer Immune Design for $300 million

Source: 
Reuters
snippet: 

Merck & Co Inc said on Thursday it would buy drug developer Immune Design Corp for nearly $300 million, to gain access to its immunotherapy programs.